tirzepatide 2.5mg injection Hush Medical Spa Mounjaro 2.5mg Tirzepatide Injection at

B., Wexler D

7157 Asian [4.49%], 25 121 Black [15.76%], and 102 381 White [64.23%]), including 79 699 patients in the semaglutide or tirzepatide group and 79 699 patients in the comparison group

There are also in-person weight-loss and telehealth options operating in and around San Antonio

It is not suitable for individuals with Type 1 diabetes or diabetic ketoacidosis

Beyond that: Consider Tirzepatide If: You want an FDA-approved, commercially available medication You have type 2 diabetes (Mounjaro is specifically approved for this) You prefer a medication with more long-term safety data Your insurance covers tirzepatide You need predictable access to medication supply Consider Waiting for Retatrutide If: You've plateaued on other GLP-1 medications You're interested in the potential metabolic benefits of glucagon activation You're comfortable waiting for FDA approval (expected 2027) You want potentially greater fat loss based on early trial data Switching From Tirzepatide to Retatrutide No established dose conversion exists

Dose changes should always be discussed with your prescribing provider